CCI clears deal involving Sekhmet Pharmaventures and Optimus Drugs Press Trust of India Aug 16, 2022 Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs
Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir for COVID-19 treatment EP News Bureau May 19, 2021 As per the clinical trial protocol approved, 2500 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1…
Optimus launches COVID-19 drug Favipiravir, commences commercial export EP News Bureau Jun 18, 2020 The drug is being marketed under the brand name Favicovid both in India and other countries